Andrew Pecora Net Worth & Insider Trades

Andrew Pecora - Director, Tetralogic Pharmaceuticals Corp

As of July 14, 2015

What is Andrew Pecora's Net Worth?

The current estimated net worth of Tetralogic Pharmaceuticals Corp's Director, Andrew Pecora, is estimated to be about $908.17K . Andrew Pecora owns about 184,830 units of Tetralogic Pharmaceuticals Corp common stock. In the last 6 months at Tetralogic Pharmaceuticals Corp, Andrew Pecora has sold an estimated value of $0 worth.

What is Andrew Pecora's Past Insider Trading?

Andrew Pecora's largest purchase order was 50,000 units , worth over $133.94K on July 14, 2015. In total, Andrew Pecora has made about 3 transactions over 6 months of their time at Tetralogic Pharmaceuticals Corp. Andrew Pecora usually trades in July, with the busiest year in 2015.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Andrew Pecora

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Andrew Pecora's' Mailing Address?

  • Mailing address is C/o Neostem, Inc. 420 Lexington Avenue, Suite 450 New York NY 10170 NY

What are Tetralogic Pharmaceuticals Corp's Past Insider Trades?

Tetralogic Pharmaceuticals Corp's most recent insider trade came on February 10, 2016 by Clarus Lifesciences Ii Lp, Clarus Ventures Ii GP Lp, Clarus Ventures Ii Llc, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, Michael Steinmetz and Kurt Wheeler who sold 333,630 units worth $56.47K . In the last 3 years, insiders at Tetralogic Pharmaceuticals Corp have sold an estimated value of $463.13K and bought an estimated value of $2.26M worth of shares. Insider trading is most common in January, with the busiest year in 2015. The most active traders at the company are Michael Steinmetz,  Clarus Lifesciences Ii Lp,  and Clarus Ventures Ii GP Lp .

TETRALOGIC PHARMACEUTICALS Corp Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...